搜索结果：AACE endocrinology and diabetes

Identifying type 2 diabetes mellitus can be challenging, particularly for primary care physicians. Clinical decision support systems incorporating artificial intelligence (AI-CDSS) can assist medical professionals in diagnosing type 2 diabetes with high accuracy. This study aimed to assess an AI-CDSS specifically developed for the diagnosis of type 2 diabetes by employing a hybrid approach that integrates expert-driven insights with machine learning techniques. The AI-CDSS was developed (training dataset: n = 650) and tested (test dataset: n = 648) using a dataset of 1298 patients with and without type 2 diabetes. To generate predictions, the algorithm utilized key features such as body mass index, plasma fasting glucose, and hemoglobin A1C. Furthermore, a clinical pilot study involving 105 patients was conducted to assess the diagnostic accuracy of the system in comparison to non-endocrinology specialists. The AI-CDSS showed a high degree of accuracy, with 99.8% accuracy in predicting diabetes, 99.3% in predicting prediabetes, 99.2% in identifying at-risk individuals, and 98.8% in predicting no diabetes. The test dataset revealed a 98.8% agreement between endocrinology specialists

Diabetes is a chronic disease with a significant global health burden, requiring multi-stakeholder collaboration for optimal management. Large language models (LLMs) have shown promise in various healthcare scenarios, but their effectiveness across diverse diabetes tasks remains unproven. Our study introduced a framework to train and validate diabetes-specific LLMs. We first developed a comprehensive data processing pipeline that includes data collection, filtering, augmentation and refinement. This created a high-quality, diabetes-specific dataset and evaluation benchmarks from scratch. Fine-tuned on the collected training dataset, our diabetes-specific LLM family demonstrated state-of-the-art proficiency in processing various diabetes tasks compared to other LLMs. Furthermore, clinical studies revealed the potential applications of our models in diabetes care, including providing personalized healthcare, assisting medical education, and streamlining clinical tasks. Generally, our introduced framework helps develop diabetes-specific LLMs and highlights their potential to enhance clinical practice and provide personalized, data-driven support for diabetes management across differen

Diabetes has emerged as a significant global health issue, especially with the increasing number of cases in many countries. This trend Underlines the need for a greater emphasis on early detection and proactive management to avert or mitigate the severe health complications of this disease. Over recent years, machine learning algorithms have shown promising potential in predicting diabetes risk and are beneficial for practitioners. Objective: This study highlights the prediction capabilities of statistical and non-statistical machine learning methods over Diabetes risk classification in 768 samples from the Pima Indians Diabetes Database. It consists of the significant demographic and clinical features of age, body mass index (BMI) and blood glucose levels that greatly depend on the vulnerability against Diabetes. The experimentation assesses the various types of machine learning algorithms in terms of accuracy and effectiveness regarding diabetes prediction. These algorithms include Logistic Regression, Decision Tree, Random Forest, K-Nearest Neighbors, Naive Bayes, Support Vector Machine, Gradient Boosting and Neural Network Models. The results show that the Neural Network algor

Understanding the complex relationships of biomarkers in diabetes is pivotal for advancing treatment strategies, a pressing need in diabetes research. This study applies Bayesian network structure learning to analyze the Shanghai Type 1 and Type 2 diabetes mellitus datasets, revealing complex relationships among key diabetes-related biomarkers. The constructed Bayesian network presented notable predictive accuracy, particularly for Type 2 diabetes mellitus, with root mean squared error (RMSE) of 18.23 mg/dL, as validated through leave-one-domain experiments and Clarke error grid analysis. This study not only elucidates the intricate dynamics of diabetes through a deeper understanding of biomarker interplay but also underscores the significant potential of integrating data-driven and knowledge-driven methodologies in the realm of personalized diabetes management. Such an approach paves the way for more custom and effective treatment strategies, marking a notable advancement in the field.

Climate change is intensifying infectious and chronic diseases like malaria and diabetes, respectively, especially among the vulnerable populations. Global temperatures have risen by approximately $0.6^\circ$C since 1950, extending the window of transmission for mosquito-borne infections and worsening outcomes in diabetes due to metabolic stress caused by heat. People living with diabetes have already weakened immune defenses and, therefore, are at an alarmingly increased risk of contraction of malaria. However, most models rarely include both ways of interaction in changing climate conditions. In the paper, we introduce a new compartmental epidemiological model based on synthetic data fitted to disease patterns of India from 2019 to 2021. The framework captures temperature-dependent transmission parameters, seasonal variability, and different disease dynamics between diabetic and non-diabetic groups within the three-compartment system. Model calibration using Multi-Start optimization combined with Sequential Quadratic Programming allows us to find outstanding differences between populations. The odds of malaria infection in diabetic individuals were found to be 1.8--4.0 times high

Background: Many studies have been conducted on the genetic and epigenetic etiology of gestational diabetes mellitus (GDM) in the last two decades because of the diseases increasing prevalence and role in the global diabetes mellitus (DM) explosion. An update on the genetic and epigenetic etiology of GDM then becomes imperative to better understand and stem the rising incidence of the disease. This review, therefore, articulated GDM candidate genes and their pathophysiology for the awareness of stakeholders. Main body (genetic and epigenetic etiology, GDM): The search discovered 83 GDM candidate genes, of which TCF7L2, MTNR1B, CDKAL1, IRS1, and KCNQ1 are the most prevalent. Certain polymorphisms of these genes can modulate beta-cell dysfunction, adiposity, obesity, and insulin resistance through several mechanisms. Environmental triggers such as diets, pollutants, and microbes may also cause epigenetic changes in these genes, resulting in a loss of insulin-boosting and glucose metabolism functions. Early detection and adequate management may resolve the condition after delivery; otherwise, it will progress to maternal type 2 diabetes mellitus (T2DM) and fetal configuration to futur

Diabetes devices, including Continuous Glucose Monitoring (CGM), Smart Insulin Pens, and Automated Insulin Delivery systems, generate rich time-series data widely used in research and machine learning. However, inconsistent data formats across sources hinder sharing, integration, and analysis. We present DIAX (DIAbetes eXchange), a standardized JSON-based format for unifying diabetes time-series data, including CGM, insulin, and meal signals. DIAX promotes interoperability, reproducibility, and extensibility, particularly for machine learning applications. An open-source repository provides tools for dataset conversion, cross-format compatibility, visualization, and community contributions. DIAX is a translational resource, not a data host, ensuring flexibility without imposing data-sharing constraints. Currently, DIAX is compatible with other standardization efforts and supports major datasets (DCLP3, DCLP5, IOBP2, PEDAP, T1Dexi, Loop), totaling over 10 million patient-hours of data. https://github.com/Center-for-Diabetes-Technology/DIAX

In this study, we delve into the intricate relationships between diabetes and a range of health indicators, with a particular focus on the newly added variable of income. Utilizing data from the 2015 Behavioral Risk Factor Surveillance System (BRFSS), we analyze the impact of various factors such as blood pressure, cholesterol, BMI, smoking habits, and more on the prevalence of diabetes. Our comprehensive analysis not only investigates each factor in isolation but also explores their interdependencies and collective influence on diabetes. A novel aspect of our research is the examination of income as a determinant of diabetes risk, which to the best of our knowledge has been relatively underexplored in previous studies. We employ statistical and machine learning techniques to unravel the complex interplay between socio-economic status and diabetes, providing new insights into how financial well-being influences health outcomes. Our research reveals a discernible trend where lower income brackets are associated with a higher incidence of diabetes. In analyzing a blend of 33 variables, including health factors and lifestyle choices, we identified that features such as high blood pres

This review explores the synthesis, characterization, and therapeutic applications of zinc oxide nanoparticles (ZnO NPs) in the treatment of diabetes mellitus. The study delves into both chemical and green synthesis methods, comparing their impacts on nanoparticle properties. Key characterization techniques such as XRD, FTIR, UV-Vis spectroscopy, and SEM confirm the crystalline structure, optical properties, and morphology of the nanoparticles. ZnO NPs demonstrate significant biological activities, including antibacterial, anti-inflammatory, and antidiabetic effects. These nanoparticles show promise in improving glucose regulation, enhancing insulin sensitivity, and boosting glucose uptake in cells. Despite these benefits, the potential toxicity and long-term effects of ZnO NPs warrant further investigation. Future research should focus on optimizing synthesis methods and conducting comprehensive studies to fully exploit ZnO NPs' potential in diabetes management and other biomedical applications.

Social media provide a platform for users to express their opinions and share information. Understanding public health opinions on social media, such as Twitter, offers a unique approach to characterizing common health issues such as diabetes, diet, exercise, and obesity (DDEO), however, collecting and analyzing a large scale conversational public health data set is a challenging research task. The goal of this research is to analyze the characteristics of the general public's opinions in regard to diabetes, diet, exercise and obesity (DDEO) as expressed on Twitter. A multi-component semantic and linguistic framework was developed to collect Twitter data, discover topics of interest about DDEO, and analyze the topics. From the extracted 4.5 million tweets, 8% of tweets discussed diabetes, 23.7% diet, 16.6% exercise, and 51.7% obesity. The strongest correlation among the topics was determined between exercise and obesity. Other notable correlations were: diabetes and obesity, and diet and obesity DDEO terms were also identified as subtopics of each of the DDEO topics. The frequent subtopics discussed along with Diabetes, excluding the DDEO terms themselves, were blood pressure, hear

The data mining along with emerging computing techniques have astonishingly influenced the healthcare industry. Researchers have used different Data Mining and Internet of Things (IoT) for enrooting a programmed solution for diabetes and heart patients. However, still, more advanced and united solution is needed that can offer a therapeutic opinion to individual diabetic and cardio patients. Therefore, here, a smart data mining and IoT (SMDIoT) based advanced healthcare system for proficient diabetes and cardiovascular diseases have been proposed. The hybridization of data mining and IoT with other emerging computing techniques is supposed to give an effective and economical solution to diabetes and cardio patients. SMDIoT hybridized the ideas of data mining, Internet of Things, chatbots, contextual entity search (CES), bio-sensors, semantic analysis and granular computing (GC). The bio-sensors of the proposed system assist in getting the current and precise status of the concerned patients so that in case of an emergency, the needful medical assistance can be provided. The novelty lies in the hybrid framework and the adequate support of chatbots, granular computing, context entity

Augmentative and Alternative Communication (AAC) technologies are categorized into two forms: aided AAC, which uses external devices like speech-generating systems to produce standardized output, and unaided AAC, which relies on body-based gestures for natural expression but requires shared understanding. We investigate how to combine these approaches to harness the speed and naturalness of unaided AAC while maintaining the intelligibility of aided AAC, a largely unexplored area for individuals with communication and motor impairments. Through 18 months of participatory design with AAC users, we identified key challenges and opportunities and developed AllyAAC, a wearable system with a wrist-worn IMU paired with a smartphone app. We evaluated AllyAAC in a field study with 14 participants and produced a dataset containing over 600,000 multimodal data points featuring atypical gestures--the first of its kind. Our findings reveal challenges in recognizing personalized, idiosyncratic gestures and demonstrate how to address them using Transformer-based large machine learning (ML) models with different pretraining strategies. In sum, we contribute design principles and a reference implem

Purpose: Understanding how the pancreas changes is critical for detecting deviations in type 2 diabetes and other pancreatic disease. We measure pancreas size and shape using morphological measurements from ages 0 to 90. Our goals are to 1) identify reliable clinical imaging modalities for AI-based pancreas measurement, 2) establish normative morphological aging trends, and 3) detect potential deviations in type 2 diabetes. Approach: We analyzed a clinically acquired dataset of 2533 patients imaged with abdominal CT or MRI. We resampled the scans to 3mm isotropic resolution, segmented the pancreas using automated methods, and extracted 13 morphological pancreas features across the lifespan. First, we assessed CT and MRI measurements to determine which modalities provide consistent lifespan trends. Second, we characterized distributions of normative morphological patterns stratified by age group and sex. Third, we used GAMLSS regression to model pancreas morphology trends in 1350 patients matched for age, sex, and type 2 diabetes status to identify any deviations from normative aging associated with type 2 diabetes. Results: When adjusting for confounders, the aging trends for 10 of

Diabetes is a global epidemic and it is increasing at an alarming rate. The International Diabetes Federation (IDF) projected that the total number of people with diabetes globally may increase by 48%, from 425 million (year 2017) to 629 million (year 2045). Moreover, diabetes had caused millions of deaths and the number is increasing drastically. Therefore, this paper addresses the background of diabetes and its complications. In addition, this paper investigates innovative applications and past researches in the areas of diabetes management system with applied eye fundus and tongue digital images. Different types of existing applied eye fundus and tongue digital image processing with diabetes management systems in the market and state-of-the-art machine learning techniques from previous literature have been reviewed. The implication of this paper is to have an overview in diabetic research and what new machine learning techniques can be proposed in solving this global epidemic.

With the continuous development and improvement of medical services, there is a growing demand for improving diabetes diagnosis. Exhaled breath analysis, characterized by its speed, convenience, and non-invasive nature, is leading the trend in diagnostic development. Studies have shown that the acetone levels in the breath of diabetes patients are higher than normal, making acetone a basis for diabetes breath analysis. This provides a more readily accepted method for early diabetes prevention and monitoring. Addressing issues such as the invasive nature, disease transmission risks, and complexity of diabetes testing, this study aims to design a diabetes gas biomarker acetone detection system centered around a sensor array using gas sensors and pattern recognition algorithms. The research covers sensor selection, sensor preparation, circuit design, data acquisition and processing, and detection model establishment to accurately identify acetone. Titanium dioxide was chosen as the nano gas-sensitive material to prepare the acetone gas sensor, with data collection conducted using STM32. Filtering was applied to process the raw sensor data, followed by feature extraction using principa

Diabetes Mellitus (DM) is a chronic disease characterized by an increase in blood glucose (sugar) above normal levels and it appears when human body is not able to produce enough insulin to cover the peripheral tissue demand. Nowadays, DM affects the 8.5% of the world's population and, even though no cure for it has been found, an adequate monitoring and treatment allow patients to have an almost normal life. This paper introduces Diabetes Link, a comprehensive platform for control and monitoring people with DM. Diabetes Link allows recording various parameters relevant for the treatment and calculating different statistical charts using them. In addition, it allows connecting with other users (supervisors) so they can monitor the controls. Even more, the extensive comparative study carried out reflects that Diabetes Link presents distinctive and superior features against other proposals. We conclude that Diabetes Link represents a broad and accessible tool that can help make day-to-day control easier and optimize the efficacy in DM control and treatment.

We present DM-Bench, the first benchmark designed to evaluate large language model (LLM) performance across real-world decision-making tasks faced by individuals managing diabetes in their daily lives. Unlike prior health benchmarks that are either generic, clinician-facing or focused on clinical tasks (e.g., diagnosis, triage), DM-Bench introduces a comprehensive evaluation framework tailored to the unique challenges of prototyping patient-facing AI solutions in diabetes, glucose management, metabolic health and related domains. Our benchmark encompasses 7 distinct task categories, reflecting the breadth of real-world questions individuals with diabetes ask, including basic glucose interpretation, educational queries, behavioral associations, advanced decision making and long term planning. Towards this end, we compile a rich dataset comprising one month of time-series data encompassing glucose traces and metrics from continuous glucose monitors (CGMs) and behavioral logs (e.g., eating and activity patterns) from 15,000 individuals across three different diabetes populations (type 1, type 2, pre-diabetes/general health and wellness). Using this data, we generate a total of 360,600

Artificial intelligence (AI) algorithms are a critical part of state-of-the-art digital health technology for diabetes management. Yet, access to large high-quality datasets is creating barriers that impede development of robust AI solutions. To accelerate development of transparent, reproducible, and robust AI solutions, we present Glucose-ML, a collection of 10 publicly available diabetes datasets, released within the last 7 years (i.e., 2018 - 2025). The Glucose-ML collection comprises over 300,000 days of continuous glucose monitor (CGM) data with a total of 38 million glucose samples collected from 2500+ people across 4 countries. Participants include persons living with type 1 diabetes, type 2 diabetes, prediabetes, and no diabetes. To support researchers and innovators with using this rich collection of diabetes datasets, we present a comparative analysis to guide algorithm developers with data selection. Additionally, we conduct a case study for the task of blood glucose prediction - one of the most common AI tasks within the field. Through this case study, we provide a benchmark for short-term blood glucose prediction across all 10 publicly available diabetes datasets with

In many nations, diabetes is becoming a significant health problem, and early identification and control are crucial. Using machine learning algorithms to predict diabetes has yielded encouraging results. Using the Pima Indians Diabetes dataset, this study attempts to evaluate the efficacy of several machine-learning methods for diabetes prediction. The collection includes information on 768 patients, such as their ages, BMIs, and glucose levels. The techniques assessed are Logistic Regression, Decision Tree, Random Forest, k-Nearest Neighbors, Naive Bayes, Support Vector Machine, Gradient Boosting, and Neural Network. The findings indicate that the Neural Network algorithm performed the best, with an accuracy of 78.57 percent, followed by the Random Forest method, with an accuracy of 76.30 percent. The study implies that machine learning algorithms can aid diabetes prediction and be an efficient early detection tool.